Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Blood sampling.
- Who it may be relevant to
- Registry conditions: Gynecological Disorders, Male Infertility, Female Infertility, Pregnancy. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Establishment of a Biobank Aimed at Studying Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies
Overview
The REPRO-Biobank has been established at San Raffaele Hospital in Milan for the purpose of collecting and preserving human biological samples and associated data. Its primary objective is to support biomedical research, with a particular focus on advancing scientific knowledge - including in the field of genetics - related to gynecological disorders, male and female infertility, and pregnancy-related conditions.
Interventions
- Other Blood sampling
Blood sampling
Primary outcome measures
- Developing a biobank/repository [Time frame: Through study completion, an average of 1 year.]
Eligibility criteria
- Affected participants
Inclusion Criteria for adult patients (including pregnant and breastfeeding women) and pediatric patients affected by:
- Male infertility
- Female infertility
- Gynecological disorders
- Pregnancy-related conditions
- Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation)
- Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients
Exclusion criteria
- Patients unable or unwilling to sign the informed consent
- Healthy participants Inclusion Criteria
- Healthy adult subjects (including pregnant and lactating women)
- Able to give informed consent for participation in the study
Exclusion criteria
- Patients unable or unwilling to sign the informed consent
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Observational model
- Cohort
Study locations
Italy · 1 center
- Irccs San Raffaele Hospital — Milan
Identifiers
NCT: NCT07265908 · REPRO-Biobank